check_circleStudy Completed
Hand Eczema
Bayer Identifier:
1401663
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema
Trial purpose
To show efficacy of Zarzenda in the treatment of hand eczema
Key Participants Requirements
Sex
BothAge
18 YearsTrial summary
Enrollment Goal
40Trial Dates
June 2007 - September 2007Phase
Phase 4Could I Receive a placebo
NoProducts
Atopiclair (Zarzenda)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Intendis GmbH | Berlin, Germany |
Primary Outcome
- Hand eczema severity index (HECSI)at the end of studydate_rangeTime Frame:End of study compared to baselineenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Investigator's Global Assessmentdate_rangeTime Frame:End of study compared to baselineenhanced_encryptionNoSafety Issue:
- Patients assessment of itchdate_rangeTime Frame:End of study compared to baselineenhanced_encryptionNoSafety Issue:
- Hand surface areadate_rangeTime Frame:End of study compared to baselineenhanced_encryptionNoSafety Issue:
- Clinical signs of hand eczemadate_rangeTime Frame:End of study compared to baselineenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DeviceTrial Purpose
TreatmentAllocation
N/ABlinding
Open LabelAssignment
Single Group AssignmentTrial Arms
1